A carregar...

Minimal residual disease in mantle cell lymphoma: insights into biology and impact on treatment

Despite the recent substantial improvement of clinical outcome in mantle cell lymphoma (MCL), resistance to immunochemotherapy and common relapses are challenges for long-term tumor control. The assessment of minimal residual disease (MRD) by real-time quantitative polymerase chain reaction has emer...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Hematology Am Soc Hematol Educ Program
Main Authors: Hoster, Eva, Pott, Christiane
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2016
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6142459/
https://ncbi.nlm.nih.gov/pubmed/27913513
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!